Annual Report 2018

Division of Innovative Pathology and Laboratory Medicine (Tsukiji Campus)

Nobuyoshi Hiraoka, Kimihiko Kawamura, Sachiyo Hasegawa

Introduction

 In the Division of Innovative Pathology and Laboratory Medicine, we develop and improve new evaluation methods to analyze the pathobiological and clinicopathological characteristics of molecules that will be useful for clinical studies in EPOC projects.

Research activities

 We took part in the study for development of a new endoscopic surgical operating system for colorectal cancer with 8K technology. We made diagnostic criteria to evaluate cancer depth by serosal observation with 8K ultra high-quality images.

Education

 Taught analytical techniques to technicians and researchers in several departments of the national cancer center.

Future prospects

 We will answer requests from selected projects in various types of studies containing basic, preclinical, and clinical studies, and assess the clinicopathological or pathobiological significance of the target molecules. We will develop methods of quantitative analysis to evaluate morphological findings that are currently analyzed qualitatively.